Koa Shoji Holdings Co.,Ltd. (TYO:9273)

Market Cap	28.18B
Revenue (ttm)	23.01B
Net Income (ttm)	3.43B
Shares Out	42.12M
EPS (ttm)	83.72
PE Ratio	7.99
Forward PE	n/a
Dividend	14.00 (2.06%)
Ex-Dividend Date	Jun 27, 2025

Volume	47,300
Average Volume	96,265
Open	685.00
Previous Close	680.00
Day's Range	668.00 - 686.00
52-Week Range	545.00 - 892.00
Beta	0.76
RSI	50.48
Earnings Date	May 12, 2025

About Koa Shoji Holdings

Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. The company is involved in the manufacture and marketing of OTC drugs and health foods; primarily various vitamins; and manufacture and sale of generic APIs and drugs, as well as pharmaceuticals comprising injections. It also engages in contract manufacturing of pharmaceuticals; packaging of pharmaceutical products; and purchase and sale of pharmaceuticals. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquarter...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 289
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9273

Financial Performance

In 2024, Koa Shoji Holdings's revenue was 22.13 billion, an increase of 0.37% compared to the previous year's 22.05 billion. Earnings were 2.95 billion, an increase of 9.64%.